AYTU BIOPHARMA, INC 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001437749-26-016721
- Form type
- 10-Q
- CIK
- 0001385818
- Primary document
- https://www.sec.gov/Archives/edgar/data/1385818/000143774926016721/aytu20260331_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AYTU BIOPHARMA, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $41.5M | - | - |
| Cost Of Revenue | $15.1M | - | - |
| Gross Profit | $26.4M | - | - |
| Operating Income | $-7.5M | - | - |
| Net Income | $-14.2M | - | - |
| Eps Basic | -1.42 | - | - |
| Eps Diluted | -1.42 | - | - |
| Cash And Equivalents | $26.7M | - | - |
| Total Assets | $111.7M | - | - |
| Shareholders Equity | $35.1M | - | - |
| Operating Cash Flow | $-1.1M | - | - |
| Capital Expenditures | $17,000 | - | - |